DOCSLIB.ORG

Inflammatory Arthritis Negatively Regulates Mouse Α PILR

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inflammatory Arthritis Negatively Regulates Mouse Α PILR PILRα Negatively Regulates Mouse Inflammatory Arthritis Yonglian Sun, Patrick Caplazi, Juan Zhang, Anita Mazloom, Sarah Kummerfeld, Gabriel Quinones, Kate Senger, Justin This information is current as Lesch, Ivan Peng, Andrew Sebrell, Wilman Luk, Yanmei of September 24, 2021. Lu, Zhonghua Lin, Kai Barck, Judy Young, Mariela Del Rio, Sophie Lehar, Vida Asghari, WeiYu Lin, Sanjeev Mariathasan, Jason DeVoss, Shahram Misaghi, Mercedesz Balazs, Tao Sai, Benjamin Haley, Philip E. Hass, Min Xu, Wenjun Ouyang, Flavius Martin, Wyne P. Lee and Ali A. Downloaded from Zarrin J Immunol published online 16 June 2014 http://www.jimmunol.org/content/early/2014/06/16/jimmun ol.1400045 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2014/06/16/jimmunol.140004 Material 5.DCSupplemental Why The JI? Submit online. by guest on September 24, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published June 16, 2014, doi:10.4049/jimmunol.1400045 The Journal of Immunology PILRa Negatively Regulates Mouse Inflammatory Arthritis Yonglian Sun,* Patrick Caplazi,† Juan Zhang,* Anita Mazloom,‡ Sarah Kummerfeld,x Gabriel Quinones,‡ Kate Senger,* Justin Lesch,* Ivan Peng,* Andrew Sebrell,{ Wilman Luk,‖ Yanmei Lu,‖ Zhonghua Lin,* Kai Barck,# Judy Young,‖ Mariela Del Rio,** Sophie Lehar,†† Vida Asghari,** WeiYu Lin,* Sanjeev Mariathasan,†† Jason DeVoss,* Shahram Misaghi,‡‡ Mercedesz Balazs,* Tao Sai,{ Benjamin Haley,‡ Philip E. Hass,‡ Min Xu,* Wenjun Ouyang,* Flavius Martin,* Wyne P. Lee,* and Ali A. Zarrin* Paired Ig-like type 2 receptor (PILR)a inhibitory receptor and its counterpart PILRb activating receptor are coexpressed on myeloid cells. In this article, we report that PILRa, but not PILRb, is elevated in human rheumatoid arthritis synovial tissue and correlates with inflammatory cell infiltration. Pilra2/2 mice produce more pathogenic cytokines during inflammation and are Downloaded from prone to enhanced autoimmune arthritis. Correspondingly, engaging PILRa with anti-PILRa mAb ameliorates inflammation in mouse arthritis models and suppresses the production of proinflammatory cytokines. Our studies suggest that PILRa mediates an important inhibitory pathway that can dampen inflammatory responses. The Journal of Immunology, 2014, 193: 000–000. mmune responses are modulated by a network of positive- ITAM-bearing DAP12 adaptor molecule to deliver activating si- and negative-regulatory mechanisms. Paired receptors consist gnals (8). Human and mouse PILRa share only ∼40% homology http://www.jimmunol.org/ I of highly related activating and inhibitory receptors that (7), yet conserved residues mediate ligand interactions (9). are widely involved in the regulation of the immune system (1). PILRa and PILRb transcripts show similar tissue expression, Both inhibitory and activating receptors share high similarity with high levels in spleen, liver, and lung and lower levels in in their extracellular domain, whereas their intracellular signal- the small intestine (8). PILRa and PILRb are predominantly ing domains are divergent (2, 3). Paired Ig-like type 2 receptor expressed in cells of the myelomonocytic lineage, including (PILR)a belongs to the Ig superfamily. Its intracellular domain monocytes, macrophages, granulocytes, and monocyte-derived contains two ITIMs that recruit SHP-1 and SHP-2 to trigger an dendritic cells (DCs) (4, 8). Additionally, PILRb is expressed in inhibitory signaling cascade, resulting in reduced intracellular NK cells (8). It was shown that PILRa binds to mouse CD99 (8), calcium mobilization (4, 5). PILRa and its gene-linked activating PILR-associating neural protein (10), and HSV-1 glycoprotein B by guest on September 24, 2021 counterpart, PILRb, share highly similar extracellular domains, (11). Specific sialylated O-linked glycans on ligands are required suggesting that they may recognize the same ligands (5–7). PILRb for their binding to PILRa (6, 10, 12). We recently identified two has a truncated cytoplasmic domain and a charged amino acid more binding partners of PILRa, neural proliferation differentia- residue in its transmembrane region that associates with the tion and control-1 and collectin-12, and found that an evolution- arily conserved PILRa domain mediates its interaction with these diverse sialylated ligands (9). This suggests that a complex net- *Department of Immunology, Genentech, South San Francisco, CA 94080; work of ligands might modulate cellular functions via PILRa.It †Department of Pathology, Genentech, South San Francisco, CA 94080; was shown that PILRa binds to HSV-1 glycoprotein B and serves ‡Department of Protein Chemistry, Genentech, South San Francisco, CA 94080; x as a virus entry coreceptor (11, 13). Previous studies showed that Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA 94080; {Department of Antibody Engineering, Genentech, South San PILRb-deficient and agonist anti-PILRa–treated mice show im- ‖ Francisco, CA 94080; Department of Biochemical and Cellular Pharmacology, Gen- proved clearance of infectious reagents and improved survival (14, entech, South San Francisco, CA 94080; #Department of Biomedical Imaging, Gen- entech, South San Francisco, CA 94080; **Department of Transgenic Technology, 15). A recent study showed that PILRa negatively regulates Genentech, South San Francisco, CA 94080; ††Department of Microbial Pathogen- neutrophil recruitment during TLR-mediated inflammatory responses ‡‡ esis, Genentech, South San Francisco, CA 94080; and Department of Early Stage (16). However, the role of PILRa or PILRb in autoimmunity is Cell Culture, Genentech, South San Francisco, CA 94080 largely unknown. Received for publication January 9, 2014. Accepted for publication May 19, 2014. Myeloid cells play a critical role in the pathophysiology of The microarray data presented in this article have been submitted to the National inflammation and autoimmunity. Rheumatoid arthritis (RA) is Center for Biotechnology Information’s Gene Expression Omnibus (http://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE48780) under accession number GSE48780. a systemic, inflammatory, autoimmune disorder manifested by Address correspondence and reprint requests to Dr. Ali A. Zarrin, Genentech, 1 DNA chronic polyarthritis with synovial hyperplasia and joint destruc- Way, South San Francisco, CA 94080. E-mail address: [email protected] tion, resulting in pain, loss of joint function, and concomitant The online version of this article contains supplemental material. reduction of life quality (17, 18). Myeloid cells, including Abbreviations used in this article: BM, bone marrow; BMDC, BM-derived DC; monocytes/macrophages and neutrophils, play an important role BMDM, BM-derived monocyte; CAIA, collagen Ab–induced arthritis; CLEC4G, in various stages of arthritis development (19, 20). To investigate C-type lectin domain family 4, member G; DC, dendritic cell; ES, embryonic stem; h, human; JCBV, joint cortical bone volume; m, mouse; micro-CT, microcomputed the role of PILRa in myeloid cell–mediated immune responses tomography; MPO, myeloperoxidase; OA, osteoarthritis; PILR, paired Ig-like type 2 and its effects on autoimmune diseases, we studied its function receptor; PNBV, periosteal new bone volume; RA, rheumatoid arthritis; WT, wild- in myeloid-driven models of RA, including collagen Ab–induced type. arthritis (CAIA) and K/BxN serum–transfer arthritis, using PILRa- Copyright Ó 2014 by The American Association of Immunologists, Inc. 0022-1767/14/$16.00 deficient mice and PILRa-specific mAbs. Murine CAIA is in- www.jimmunol.org/cgi/doi/10.4049/jimmunol.1400045 2 PILRa REGULATES INFLAMMATION ducedbyi.v.injectionofmAbsagainst type II collagen, fol- mAbswasconfirmedbyELISAandflowcytometryanalysis.ThesemAbsdo lowedbyi.p.injectionofLPS.Thismodeliswidelyusedto not cross-react with mouse PILRb. Hamster anti-PILRa mAb was used for study the pathogenesis of autoimmune arthritis and to determine staining, and mouse anti-PILRa mAb was used for in vivo and in vitro functional studies. efficacy of therapeutics (21–24). Myeloid cells, FcgRs (22), and proinflammatory cytokines, especially TNF-a and IL-1b (21), are Gene expression analysis indispensable for the development and maintenance of arthritis in For gene expression analysis, total RNA was isolated using TRIzol reagent this model (23). The K/BxN serum–transfer arthritis model is (Invitrogen). Total RNA (50 ng) was subjected to RT-PCR using Access RT- induced by transferring K/BxN serum into normal mice; LPS is PCR System (Promega). Primers used for amplification were as follows: not needed in this model. The K/BxN serum–transfer arthritis b-actin, sense primer: 59-TACCTCATGAAGATCCTCA-39 and antisense model shares multiple features with human RA, including sym-
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants
    A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Fritsche, L. G., W. Igl, J. N. Cooke Bailey, F. Grassmann, S. Sengupta, J. L. Bragg-Gresham, K. P. Burdon, et al. 2016. “A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.” Nature genetics 48 (2): 134-143. doi:10.1038/ng.3448. http:// dx.doi.org/10.1038/ng.3448. Published Version doi:10.1038/ng.3448 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27662298 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Genet Manuscript Author . Author manuscript; Manuscript Author available in PMC 2016 June 21. Published in final edited form as: Nat Genet. 2016 February ; 48(2): 134–143. doi:10.1038/ng.3448. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants A full list of authors and affiliations appears at the end of the article. Abstract Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly with limited therapeutic options. Here, we report on a study of >12 million variants including 163,714 directly genotyped, most rare, protein-altering variant.
    [Show full text]
  • Blood Flow Guides Sequential Support of Neutrophil Arrest and Diapedesis
    RESEARCH ARTICLE Blood flow guides sequential support of neutrophil arrest and diapedesis by PILR-b 1 and PILR-a Yu-Tung Li, Debashree Goswami†, Melissa Follmer, Annette Artz, Mariana Pacheco-Blanco, Dietmar Vestweber* Vascular Cell Biology, Max Planck Institute of Molecular Biomedicine, Mu¨ nster, Germany Abstract Arrest of rapidly flowing neutrophils in venules relies on capturing through selectins and chemokine-induced integrin activation. Despite a long-established concept, we show here that gene inactivation of activating paired immunoglobulin-like receptor (PILR)-b1 nearly halved the efficiency of neutrophil arrest in venules of the mouse cremaster muscle. We found that this receptor binds to CD99, an interaction which relies on flow-induced shear forces and boosts chemokine-induced b2-integrin-activation, leading to neutrophil attachment to endothelium. Upon arrest, binding of PILR-b1 to CD99 ceases, shifting the signaling balance towards inhibitory PILR-a. This enables integrin deactivation and supports cell migration. Thus, flow-driven shear forces guide sequential signaling of first activating PILR-b1 followed by inhibitory PILR-a to prompt neutrophil arrest and then transmigration. This doubles the efficiency of selectin-chemokine driven neutrophil arrest by PILR-b1 and then supports transition to migration by PILR-a. DOI: https://doi.org/10.7554/eLife.47642.001 *For correspondence: [email protected] Present address: †Center for Global Infectious Disease Introduction Research, Seattle Childrens Host defense against pathogens depends on the recruitment of leukocytes to sites of infections Research Institute, Seattle, (Ley et al., 2007). Selectins capture leukocytes to the endothelial cell surface by binding to glyco- United States conjugates (McEver, 2015).
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Epistatic Interactions of Genetic Loci Associated with Age-Related
    www.nature.com/scientificreports OPEN Epistatic interactions of genetic loci associated with age‑related macular degeneration Christina Kiel1,3, Christoph A. Nebauer1,3, Tobias Strunz1,3, Simon Stelzl1 & Bernhard H. F. Weber 1,2* The currently largest genome‑wide association study (GWAS) for age‑related macular degeneration (AMD) defnes disease association with genome‑wide signifcance for 52 independent common and rare genetic variants across 34 chromosomal loci. Overall, these loci contain over 7200 variants and are enriched for genes with functions indicating several shared cellular processes. Still, the precise mechanisms leading to AMD pathology are largely unknown. Here, we exploit the phenomenon of epistatic interaction to identify seemingly independent AMD‑associated variants that reveal joint efects on gene expression. We focus on genetic variants associated with lipid metabolism, organization of extracellular structures, and innate immunity, specifcally the complement cascade. Multiple combinations of independent variants were used to generate genetic risk scores allowing gene expression in liver to be compared between low and high‑risk AMD. We identifed genetic variant combinations correlating signifcantly with expression of 26 genes, of which 19 have not been associated with AMD before. This study defnes novel targets and allows prioritizing further functional work into AMD pathobiology. A frst successful genome-wide association study (GWAS) was reported in 2005 and identifed with genome- wide signifcance genetic variants at the CFH locus associated with age-related macular degeneration (AMD), a complex disease which is a frequent cause of progressive vision loss in the elderly population 1. Since then, the list of AMD-associated genetic variation has grown exponentially, presently bringing the total to 52 independent common and rare variants across 34 chromosomal loci2.
    [Show full text]
  • Identification of Key Pathways and Genes in Dementia Via Integrated Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract To provide a better understanding of dementia at the molecular level, this study aimed to identify the genes and key pathways associated with dementia by using integrated bioinformatics analysis. Based on the expression profiling by high throughput sequencing dataset GSE153960 derived from the Gene Expression Omnibus (GEO), the differentially expressed genes (DEGs) between patients with dementia and healthy controls were identified. With DEGs, we performed a series of functional enrichment analyses. Then, a protein–protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network was constructed, analyzed and visualized, with which the hub genes miRNAs and TFs nodes were screened out. Finally, validation of hub genes was performed by using receiver operating characteristic curve (ROC) analysis.
    [Show full text]
  • Prioritizing Parkinson’S Disease Genes Using Population-Scale
    ARTICLE https://doi.org/10.1038/s41467-019-08912-9 OPEN Prioritizing Parkinson’s disease genes using population-scale transcriptomic data Yang I. Li1, Garrett Wong2, Jack Humphrey 3,4 & Towfique Raj2 Genome-wide association studies (GWAS) have identified over 41 susceptibility loci asso- ciated with Parkinson’s Disease (PD) but identifying putative causal genes and the underlying mechanisms remains challenging. Here, we leverage large-scale transcriptomic datasets to 1234567890():,; prioritize genes that are likely to affect PD by using a transcriptome-wide association study (TWAS) approach. Using this approach, we identify 66 gene associations whose predicted expression or splicing levels in dorsolateral prefrontal cortex (DLFPC) and peripheral monocytes are significantly associated with PD risk. We uncover many novel genes associated with PD but also novel mechanisms for known associations such as MAPT, for which we find that variation in exon 3 splicing explains the common genetic association. Genes identified in our analyses belong to the same or related pathways including lysosomal and innate immune function. Overall, our study provides a strong foundation for further mechanistic studies that will elucidate the molecular drivers of PD. 1 Section of Genetic Medicine, Department of Medicine, and Department of Human Genetics, University of Chicago, Chicago 60637 IL, USA. 2 Departments of Neuroscience, and Genetics and Genomic Sciences, Ronald M. Loeb Center for Alzheimer’s disease, Icahn School of Medicine at Mount Sinai, New York 10029 NY, USA. 3 UCL Genetics Institute, Gower Street, London WC1E 6BT, UK. 4 Department of Neurodegenerative Disease, UCL Institute of Neurology, London WC1E 6BT, UK. These authors contributed equally: Yang I.
    [Show full text]
  • A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants
    A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Lars G. Fritsche1†, Wilmar Igl2†, Jessica N. Cooke Bailey3†, Felix Grassmann4†, Sebanti Sengupta1†, Jennifer L. Bragg-Gresham1,5, Kathryn P. Burdon6, Scott J. Hebbring7, Cindy Wen8, Mathias Gorski2, Ivana K. Kim9, David Cho10, Donald Zack11,12,13,14,15, Eric Souied16, Hendrik P. N. Scholl11,17, Elisa Bala18, Kristine E. Lee19, David J. Hunter20,21, Rebecca J. Sardell22, Paul Mitchell23, Joanna E. Merriam24, Valentina Cipriani25,26, Joshua D. Hoffman27, Tina Schick28, Yara T. E. Lechanteur29, Robyn H. Guymer30, Matthew P. Johnson31, Yingda Jiang32, Chloe M. Stanton33, Gabriëlle H. S. Buitendijk34,35, Xiaowei Zhan1,36,37, Alan M. Kwong1, Alexis Boleda38, Matthew Brooks39, Linn Gieser38, Rinki Ratnapriya38, Kari E. Branham39, Johanna R. Foerster1, John R. Heckenlively39, Mohammad I. Othman39, Brendan J. Vote6, Helena Hai Liang30, Emmanuelle Souzeau40, Ian L. McAllister41, Timothy Isaacs41, Janette Hall40, Stewart Lake40, David A. Mackey6,30,41, Ian J. Constable41, Jamie E. Craig40, Terrie E. Kitchner7, Zhenglin Yang42,43, Zhiguang Su44, Hongrong Luo8,44, Daniel Chen8, Hong Ouyang8, Ken Flagg8, Danni Lin8, Guanping Mao8, Henry Ferreyra8, Klaus Stark2, Claudia N. von Strachwitz45, Armin Wolf46, Caroline Brandl2,4,47, Guenther Rudolph46, Matthias Olden2, Margaux A. Morrison48, Denise J. Morgan48, Matthew Schu49,50,51,52,53, Jeeyun Ahn54, Giuliana Silvestri55, Evangelia E. Tsironi56, Kyu Hyung Park57, Lindsay A. Farrer49,50,51,52,53, Anton Orlin58, Alexander Brucker59, Mingyao Li60, Christine Curcio61, Saddek Mohand-Saïd62,63,64,65, José-Alain Sahel62,63,64,65,66,67,68, Isabelle Audo62,63,64,69, Mustapha Benchaboune65, Angela J.
    [Show full text]
  • Dysfunctional Chromatin Relations in Neurological Diseases
    fgene-12-732033 August 2, 2021 Time: 15:24 # 1 REVIEW published: 05 August 2021 doi: 10.3389/fgene.2021.732033 Loop Interrupted: Dysfunctional Chromatin Relations in Neurological Diseases Marthe Behrends1 and Olivia Engmann2* 1 Faculty of Medicine, Friedrich Schiller Universität, Jena, Thüringen, Germany, 2 Jena University Hospital, Institute for Human Genetics, Thüringen, Germany The majority of genetic variants for psychiatric disorders have been found within non-coding genomic regions. Physical interactions of gene promoters with distant regulatory elements carrying risk alleles may explain how the latter affect gene expression. Recently, whole genome maps of long-range chromosomal contacts from human postmortem brains have been integrated with gene sequence and chromatin accessibility data to decipher disease-specific alterations in chromatin architecture. Cell culture and rodent models provide a causal link between chromatin conformation, long- Edited by: range chromosomal contacts, gene expression, and disease phenotype. Here, we give Ali Jawaid, Nencki Institute of Experimental an overview of the techniques used to study chromatin contacts and their limitations Biology (PAS), Poland in brain research. We present evidence for three-dimensional genome changes in Reviewed by: physiological brain function and assess how its disturbance contributes to psychiatric Dag H. Yasui, University of California, Davis, disorders. Lastly, we discuss remaining questions and future research directions with a United States focus on clinical applications. Jiantao Shi, Shanghai Institute of Biochemistry Keywords: chromatin architecture, looping, mental illness, addiction, Alzheimer’s disease and Cell Biology, Chinese Academy of Sciences (CAS), China *Correspondence: THE 3D GENOME Olivia Engmann [email protected] The linear sequence of DNA contains the information to build individual components of a cell, tissue or organism.
    [Show full text]
  • Manifestations of Genetic Risk for Alzheimer's Disease in the Blood
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.26.437267; this version posted March 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Manifestations of genetic risk for Alzheimer’s Disease in the blood: a cross-sectional multi- omic analysis in healthy adults aged 18-90+ Laura Heath1,2,*, John C. Earls1,3, Andrew T. Magis1, Sergey A. Kornilov1, Jennifer C. Lovejoy1, Cory C. Funk1, Noa Rappaport1, Benjamin A. Logsdon2, Lara M. Mangravite2, Brian W. Kunkle4,5, Eden R. Martin4,5, Adam C. Naj6,7, Nilüfer Ertekin-Taner8,9, Todd E. Golde10, Leroy Hood1,10, Nathan D. Price1,3,*, Alzheimer’s Disease Genetics Consortium 1Institute for Systems Biology, Seattle, WA 2Sage Bionetworks, Seattle, WA 3Onegevity, a division of Thorne HealthTech, New York, NY 4John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 5Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL 6Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 7Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 8Mayo Clinic, Department of Neurology, Jacksonville, FL 9Mayo Clinic, Department of Neuroscience, Jacksonville, FL 10Department of Neuroscience, College of Medicine, Center for Translational Research in Neurodegenerative Disease University of Florida, McKnight Brain Institute, Gainesville, FL 11Providence St.
    [Show full text]
  • Differentially Expressed Genes in Aneurysm Tissue Compared With
    On-line Table: Differentially expressed genes in aneurysm tissue compared with those in control tissue Fold False Discovery Direction of Gene Entrez Gene Name Function Change P Value Rate (q Value) Expression AADAC Arylacetamide deacetylase Positive regulation of triglyceride 4.46 1.33E-05 2.60E-04 Up-regulated catabolic process ABCA6 ATP-binding cassette, subfamily A (ABC1), Integral component of membrane 3.79 9.15E-14 8.88E-12 Up-regulated member 6 ABCC3 ATP-binding cassette, subfamily C (CFTR/MRP), ATPase activity, coupled to 6.63 1.21E-10 7.33E-09 Up-regulated member 3 transmembrane movement of substances ABI3 ABI family, member 3 Peptidyl-tyrosine phosphorylation 6.47 2.47E-05 4.56E-04 Up-regulated ACKR1 Atypical chemokine receptor 1 (Duffy blood G-protein–coupled receptor signaling 3.80 7.95E-10 4.18E-08 Up-regulated group) pathway ACKR2 Atypical chemokine receptor 2 G-protein–coupled receptor signaling 0.42 3.29E-04 4.41E-03 Down-regulated pathway ACSM1 Acyl-CoA synthetase medium-chain family Energy derivation by oxidation of 9.87 1.70E-08 6.52E-07 Up-regulated member 1 organic compounds ACTC1 Actin, ␣, cardiac muscle 1 Negative regulation of apoptotic 0.30 7.96E-06 1.65E-04 Down-regulated process ACTG2 Actin, ␥2, smooth muscle, enteric Blood microparticle 0.29 1.61E-16 2.36E-14 Down-regulated ADAM33 ADAM domain 33 Integral component of membrane 0.23 9.74E-09 3.95E-07 Down-regulated ADAM8 ADAM domain 8 Positive regulation of tumor necrosis 4.69 2.93E-04 4.01E-03 Up-regulated factor (ligand) superfamily member 11 production ADAMTS18
    [Show full text]
  • Alzheimer's Disease Risk Polymorphisms Regulate
    RESEARCH ARTICLE Alzheimer’s Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci Celeste M. Karch1,2*, Lubov A. Ezerskiy1, Sarah Bertelsen3, Alzheimer’s Disease Genetics Consortium (ADGC)¶, Alison M. Goate3* 1 Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2 Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3 Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, United States of America ¶ Membership of the Alzheimer’s Disease Genetics Consortium is provided in the Acknowledgments. * [email protected] (CMK); [email protected] (AMG) Abstract OPEN ACCESS Late onset Alzheimer’s disease (LOAD) is a genetically complex and clinically heteroge- Citation: Karch CM, Ezerskiy LA, Bertelsen S, Alzheimer’s Disease Genetics Consortium (ADGC), neous disease. Recent large-scale genome wide association studies (GWAS) have identi- Goate AM (2016) Alzheimer’s Disease Risk fied more than twenty loci that modify risk for AD. Despite the identification of these loci, Polymorphisms Regulate Gene Expression in the little progress has been made in identifying the functional variants that explain the associa- ZCWPW1 and the CELF1 Loci. PLoS ONE 11(2): e0148717. doi:10.1371/journal.pone.0148717 tion with AD risk. Thus, we sought to determine whether the novel LOAD GWAS single nucleotide polymorphisms (SNPs) alter expression of LOAD GWAS genes and whether Editor: Qingyang Huang, Central China Normal University, CHINA expression of these genes is altered in AD brains.
    [Show full text]